RYTHM, Inc. (RYM) AI Stock Analysis

RYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. The company offers consumers hemp-derived tetrahydrocannabinol beverages and other hemp-derived products through retailers, online channels, and direct-to-retail partnerships. Its beverage lineup includes four cocktail flavors: classic Lime Jalapeño Margarita, Mango Margarita, Paloma, and Ranch Water, positioned as alternatives to alcoholic drinks. In addition, the company licenses its brands for manufacturing and distribution. Products are sold under brands including RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's, Good Green, and Señorita. Formerly known as Agrify Corporation, the company changed its name to RYTHM, Inc. in August 2025.

Annual revenue fluctuated significantly from FY2021 to FY2025, falling from $59.9M in FY2021 to $9.7M in FY2024 before rebounding 78.5% to $17.3M in FY2025. Over the 5-year period from FY2020 to FY2025, revenue generated a CAGR of 7.4%. Gross margin improved to 59.0% in FY2025, up from 6.9% in FY2024, but operating margin remained negative at -138.1%, contributing to a net loss of -$33.3M and an EPS of -$17.28. Over the trailing twelve months ended June 30, 2026, revenue stood at $51.0M with an operating margin of 8.4% and an EPS of -$10.45, supported by a latest quarterly year-over-year revenue expansion of 1027.4%.

As of June 30, 2026, RYTHM held $41.9M in cash and short-term investments alongside total debt of $80.6M, resulting in net debt of $38.7M. The current ratio stood at 0.59, and the debt-to-equity ratio was 2.06 against shareholders' equity of $39.1M out of $135.4M in total assets. Cash flow remained under pressure in FY2025, with operating cash flow and free cash flow both reporting -$23.5M. Capital deployment in FY2025 included $337,000 directed toward share buybacks, while the share count expanded 3273.7% over 5 years.

With a market cap of $36.9M and enterprise value of $88.8M, RYTHM trades at a price-to-sales multiple of 0.7x, matching the 0.7x median of its US-listed Consumer Defensive peers. Its enterprise value-to-revenue multiple is 1.7x, and its price-to-book ratio is 1.3x. Over the past year, the stock has declined 62.5%, compared to a 16.8% gain for the S&P 500 (SPY). Over a 5-year period, RYM shares fell 100.0%, trailing the 83.0% return of the benchmark index.

RYTHM has beaten EPS estimates in 2 of the last 4 quarters. The company's next earnings report is scheduled for November 6, 2026. The stock closed at $17.16 on October 16, 2026, which is 22.8% below its 200-day moving average.

This page is an AI-written research summary of RYTHM, Inc. (RYM). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: RYM income statement, RYM balance sheet, RYM key metrics, RYM chart. See the RYM stock overview for the latest quote and news.